Creative Biosciences

Core Principles Driving Our Mission

Global Impact, Local Insight

Leverage our international presence to address global health challenges with regionally relevant, scalable solutions.

Relentless Scientific Innovation

Advance the frontiers of biotechnology through continuous R&D, pioneering new diagnostics, and technologies.

Precision & Quality Without Compromise

Deliver rigorously validated, high-accuracy solutions that meet the highest scientific and clinical standards.

Regulatory Excellence

Ensure full compliance with global regulatory frameworks, prioritizing patient safety, data integrity, and ethical responsibility.

Patient-Centric

Develop every product and solution with the needs of patients at the center.

Collaborative Discovery

Build strategic alliances across academia, industry, and healthcare to accelerate breakthroughs and shared success.

Colosafe ®

Methylation Detection Kit for Human SDC2 Gene(Real time PCR)， It was the first approved of its kind by NMPA on November 20, 2018.

First NMPA-approved stool DNA test kit for early detection of colorectal cancer

Product Pipeline

Lunsafe^®

Automatic Sample Preprocessing Instrument

Automatic Nucleic Acid Extraction Instrument H24

HemoPOC^® Coagulometer

HelixPOC^® Automated Microfluidic qPCR System

Colosafe ®

Publications

1 .Stool DNA Test of Methylated Syndecan-2 for the Early Detection of Colorectal Neoplasia

2 .Robust performance of a novel stool DNA test of methylated SDC2 for colorectal cancer detection a multicenter clinical study

3 .A novel stool-based SDC2 DNA methylation test is more robust than FIT and plasma CEA in detecting colorectal neoplasia in China

Media Center

Creative Biosciences Releases Annual Real-World Application Data from Over 1.29 Million Colosafe® Tests

Jan 12, 2026

January 12, 2026, Guangzhou, China, Creative Biosciences, a leader in fecal DNA–based colorectal cancer screening in China, has released its annual update of real-world application data for Colosafe, the company’s proprietary early colorectal cancer screen

Core Principles Driving Our Mission

Global Impact, Local Insight

Relentless Scientific Innovation

Precision & Quality Without Compromise

Regulatory Excellence

Patient-Centric

Collaborative Discovery

Lunsafe®